PanGPCR: predictions for multiple targets, repurposing and side effects

Bioinformatics. 2021 May 23;37(8):1184-1186. doi: 10.1093/bioinformatics/btaa766.

Abstract

Summary: Drug discovery targeting G protein-coupled receptors (GPCRs), the largest known class of therapeutic targets, is challenging. To facilitate the rapid discovery and development of GPCR drugs, we built a system, PanGPCR, to predict multiple potential GPCR targets and their expression locations in the tissues, side effects and possible repurposing of GPCR drugs. With PanGPCR, the compound of interest is docked to a library of 36 experimentally determined crystal structures comprising of 46 docking sites for human GPCRs, and a ranked list is generated from the docking studies to assess all GPCRs and their binding affinities. Users can determine a given compound's GPCR targets and its repurposing potential accordingly. Moreover, potential side effects collected from the SIDER (Side-Effect Resource) database and mapped to 45 tissues and organs are provided by linking predicted off-targets and their expressed sequence tag profiles. With PanGPCR, multiple targets, repurposing potential and side effects can be determined by simply uploading a small ligand.

Availability and implementation: PanGPCR is freely accessible at https://gpcrpanel.cmdm.tw/index.html.

Supplementary information: Supplementary data are available at Bioinformatics online.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Discovery
  • Drug Repositioning*
  • Humans
  • Ligands
  • Receptors, G-Protein-Coupled* / genetics

Substances

  • Ligands
  • Receptors, G-Protein-Coupled